BlackRock Amends USANA Health Sciences Stake as of Dec 31, 2023

Ticker: USNA · Form: SC 13G/A · Filed: 2024-01-24T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investment

TL;DR

**BlackRock just updated its USANA Health Sciences stake, signaling a portfolio adjustment.**

AI Summary

BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating a change in its ownership stake in USANA Health Sciences Inc. as of December 31, 2023. This filing, an amendment number 4, updates BlackRock's passive investment position in USANA's Common Stock. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence or strategy regarding USANA, potentially influencing other investors.

Why It Matters

This filing shows BlackRock, a massive investment firm, updated its ownership in USANA Health Sciences, which can be seen as a vote of confidence or a strategic adjustment by a major player.

Risk Assessment

Risk Level: low — This is a routine update from a passive institutional investor and doesn't indicate any immediate significant risk or opportunity.

Analyst Insight

Investors should note BlackRock's continued presence as a shareholder, but this routine update doesn't necessitate immediate action. It's a data point for understanding institutional interest.

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 4, as stated in the filing.

Who is the filer of this SC 13G/A?

The filer of this SC 13G/A is BlackRock Inc., as indicated in the 'FILED BY' section of the filing.

What is the subject company of this filing?

The subject company is USANA HEALTH SCIENCES INC, as stated under 'SUBJECT COMPANY' and 'Name of Issuer' in the filing.

What was the date of the event that required this filing?

The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' next to '[X] Rule 13d-1(b)' in the filing.

From the Filing

0001086364-24-002660.txt : 20240124 0001086364-24-002660.hdr.sgml : 20240124 20240124172354 ACCESSION NUMBER: 0001086364-24-002660 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-55565 FILM NUMBER: 24557799 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us90328m1071_012424.txt us90328m1071_012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) USANA HEALTH SCIENCES INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 90328M107 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 90328M107 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 1816586 (6) Shared voting power 0 (7) Sole dispositive power 1836679 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 1836679 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 9.6% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- USANA HEALTH SCIENCES INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 Item 2. 2(a) Name of pe

View on Read The Filing